Evidence map›Paper›PMID 26209818›Full record

ArticleStem cell research2015

REST-miR-21-SOX2 axis maintains pluripotency in E14Tg2a.4 embryonic stem cells.

Sanjay K Singh, Anantha Marisetty, Pratheesh Sathyan, Mohamedi Kagalwala, Zhaoyang Zhao, Sadhan Majumder

Open access · goldAbstract read
In one paragraph

Article in Stem cell research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. REST in the Road Map of Brain Development.Cellular and molecular neurobiology · 2023
    Review
  4. Review
  5. Article
  6. CRISPR-Cas knockout of miR21 reduces glioma growth.Molecular therapy oncolytics · 2022
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Local Delivery of miR-21 Stabilizes Fibrous Caps in Vulnerable Atherosclerotic Lesions.Molecular therapy : the journal of the American Society of Gene Therapy · 2018
    Article
  14. Article
  15. The Importance of REST for Development and Function of Beta Cells.Frontiers in cell and developmental biology · 2017
    Review
  16. Article
  17. Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sanjay K SinghDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Anantha MarisettyDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Pratheesh SathyanDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Mohamedi KagalwalaDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Zhaoyang ZhaoDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Sadhan MajumderDepartment of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; The Brain Tumor Center, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Program in Genes and Development, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, TX 77030, USA. Electronic address: ssinghk@gmail.com.
The University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
REST/NRSF-mediated medulloblastoma tumorigenesisR01CA097124 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MAJUMDER, SADHAN · 2002 to 2013
$2.9M
Implications of a novel glioblastoma classification defined by miR-21-Sox2 statusR01NS081684 · NINDS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MAJUMDER, SADHAN · 2012 to 2015
$1.5M
NCI NIH HHS CA016672NCI NIH HHS CA97124NCI NIH HHS P30 CA016672NCI NIH HHS R01 CA097124NINDS NIH HHS NS081684NINDS NIH HHS R01 NS081684
6 · The paper itself

Abstract

Our previous studies have shown that the regulatory network that maintains pluripotency in mouse embryonic stem cells (mESCs) is regulated in a context-dependent manner and can be modulated, at least in part, by re-calibration of an intracellular network of pluripotency factors as well as cues arising from the extracellular matrix. The transcriptional repressor REST represses miR-21 and, thus, regulates self-renewal in E14Tg2a.4 mESCs cultured in the absence of mouse embryonic fibroblast feeder cell effects. However, how miR-21 connects to the nuclear regulatory network has not been clear. Here, we show that miR-21, a direct target of REST-mediated repression, directly targets Sox2. Exogenously added miR-21 to mESCs decreases the expression of Sox2, decreasing mESC self-renewal, and this effect of miR-21 on mESC self-renewal can be blocked by expression of exogenous Sox2. Conversely, destabilization of Sox2 by miR-21 can be blocked by anti-miR-21. Thus, the REST-miR-21-Sox2 axis connects REST to the core nuclear pluripotency regulators in E14Tg2a.4 mESCs cultured in the absence of feeder cells.

Indexed as

3' Untranslated RegionsAnimalsBase SequenceBinding SitesCell LineEmbryonic Stem CellsMiceMicroRNAsOctamer Transcription Factor-3RE1-Silencing Transcription FactorRepressor ProteinsRNA InterferenceRNA, MessengerRNA, Small InterferingSequence AlignmentSOXB1 Transcription Factors3' Untranslated RegionsMicroRNAsMIRN21 microRNA, mouseOctamer Transcription Factor-3Pou5f1 protein, mouseRE1-Silencing Transcription FactorRepressor ProteinsRNA, MessengerRNA, Small InterferingSox2 protein, mouseSOXB1 Transcription FactorsREST-miR-21-Sox2 axis in mESC pluripotency

Identifiers

PMID26209818
PMCPMC4654943
OpenAlexW1782264743

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.